Log in to save to my catalogue

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d9d5882dc6bc40909de99e9dcc12e483

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

About this item

Full title

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2022-02, Vol.27 (5), p.1481

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of mortality. The potential factors causing PF include viral infections, radiation exposure, and toxic airborne chemicals. Idiopathic PF (IPF) is related to pneumonia affecting the elderly and is characterized by recurring scar formation in the lungs. An impaired...

Alternative Titles

Full title

Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d9d5882dc6bc40909de99e9dcc12e483

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d9d5882dc6bc40909de99e9dcc12e483

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules27051481

How to access this item